MannKind Corp
MNKD
#5719
Rank
C$1.86 B
Marketcap
C$6.05
Share price
0.47%
Change (1 day)
18.88%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): C$3.04 Million

According to MannKind Corp's latest financial reports the company's current earnings are C$0.34 Billion. a decrease over its 2024 earnings that were of C$43.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 C$1.99 M-95.39%
2024 C$43.33 M-394.09%
2023 -C$14.74 Million-88.13%
2022 -C$0.13 Billion8%
2021 -C$0.12 Billion40.84%
2020 -C$81.6 Million10.7%
2019 -C$73.71 Million-40.16%
2018 -C$0.13 Billion-26.04%
2017 -C$0.17 Billion-193.33%
2016 C$0.17 B-134.11%
2015 -C$0.53 Billion85.72%
2014 -C$0.29 Billion3.6%
2013 -C$0.28 Billion12.79%
2012 -C$0.25 Billion5.58%
2011 -C$0.23 Billion-5.72%
2010 -C$0.25 Billion-22.51%
2009 -C$0.32 Billion-27.37%
2008 -C$0.44 Billion3.36%
2007 -C$0.42 Billion27.18%
2006 -C$0.33 Billion101.63%
2005 -C$0.17 Billion50.46%
2004 -C$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$15.03 B 752,636.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
C$35.51 B 1,777,575.91%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
C$44.19 B 2,212,053.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.67 B 934,654.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
C$0.66 B 33,082.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-C$0.23 Billion-11,150.96%๐Ÿ‡บ๐Ÿ‡ธ USA